• 专利附录
  • 专利说明
  • 权利要求
  • 类似技术
  • 同族专利
  • 引用文献
  • 法律状态
  • 优先权
    • 专利摘要:
    The invention relates to molecularbiology and biotechnology, in particular to the use of cell-free translation systems for the synthesis of biologically active polypeptides in vitro. The aim of the invention is to increase the yield of the target product by increasing the life of the broadcast system. The method of preparative synthesis of polypeptides and proteins in a cell-free system of translation of continuous action implies continuous removal of reaction products from the reaction mixture and continuous restoration of the initial concentration of low-molecular substances consumed in the process of translation.
    公开号:SU1618761A1
    申请号:SU4239148K
    申请日:1987-04-29
    公开日:1991-01-07
    发明作者:Юлий Борисович Алахов；Владимир Иванович Баранов；Сергей Юрьевич Оводов；Любовь Анатольевна Рябова；Александр Сергеевич Спирин
    申请人:Институт Белка Ан Ссср；
    IPC主号:
    专利说明:

    The invention relates to molecular biology and biotechnology, namely to the use of cell-free translation systems for the synthesis of biologically active polypeptides in vitro.
    The aim of the invention is to increase the yield of the target product by increasing the lifetime of the broadcast system.
    Figures 1 and 2 show diagrams, as shown below.
    A number of cell-free translation systems have been developed based on cellular extracts from various prokaryotic and eukaryotic organisms. All these systems are characterized by low efficiency of the process and usually provide for the synthesis of only a few polypeptide molecules per ribosome. The main reasons for the low efficiency of cell-free translation systems
    consists in the fact that cell-free translation systems contain a limited number of reaction substrates, primarily energy sources (ATP and OTP). An increase in the content of these components in systems has certain limits, above which an inhibition of the translation system is observed. Decomposition products of reaction substrates, first of all
    ADP, AMP, CDP, phosphates and pyrophosphates are inhibitors of the translation system. The synthesis products themselves (polypeptides) can also be inhibitors of individual stages of the cell-free translation system.
    The reasons described are eliminated due to the continuous removal of the reaction products from the reaction mixture and the continuous reduction of the initial mixture.
    concentration of low molecular weight substances consumed during the translation process.
    The main reaction (synthesis) of the polypeptide proceeds in block 1 (Fig. 1). As a result, it is consumed by free amino acids, ATP and GTP, and forms a polypeptide, AMP, GDP and inorganic phosphate. In order to prevent the process from block 1 from being simultaneously sampled, GDP, AMP and P, and iGTP, ATP and amino acid feeds from block 2. The selection of the synthesized polypeptide occurs (in block 3) through the membrane into the reservoir from which the buffer; in a column with affinity immunosorbent. On the column, the polypeptide is adsorbed on an immune sorbent specific for the target polypeptide. The more economical operation of the system in block 4 converts the resulting AMP and GDP into ATP and GTP. After the adsorption of the polypeptide, the buffer solution from block 3 also passes through the ATP and GTP regeneration system and re-enters the reaction mixture through a semipermeable membrane.
    Example 1. Synthesis of a fire mosaic virus shell (BMV) protein on a BMV RNA 4 template in a eukaryotic translation system from wheat germ in a standard system and in a continuous plant.
    Solution (A) consists of 20 mM HE
    PES, pH 7.6, 2.1 mM Mg (oAc) 2, 115 mM CoAc, 1 mM ATP, 25 µM GTP, 250 µM spermidine, 25 µM Ј IIJ leucine with a specific radioactivity of 24 Ci / mmol and 25 µM each the remaining 19 amino acids. 3 ml of the incubation mixture prepared in solution (A) contains 80 pmol 08 S ribosomes, 20 pmol BMV RNA 4, 3.7 op.ed. A2gg protein fraction S100, 150 units. ribonuclease inhibitor from human placenta, 0.1 μg leupeptin, 0.1 μg apotenin, 0.1 μg pepstatin, 0.1 μg chymostatin. t
    The kinetics of envelope protein synthesis in the standard system at 25 C is presented in Fig. 2 (curve 1).
    In a parallel experiment in a continuous installation, solution (A) is continuously supplied to 3 ml of the same incubation mixture at a rate of 0.6 ml / h, and the reaction products are withdrawn from the reaction mixture at the same rate through an ultrafiltration
    0 5
    0
    five
    0
    five
    0
    five
    membrane HM-50. As a result, reaction substrates (ATP, GTP, amino acids) are continuously fed into the chamber containing the cell-free translation system and the reaction products (AMP, GDP, P., synthesized envelope protein) are removed from it.
    The kinetics of the synthesis of the protein shell in such a system at 25 ° C for 15 hours is presented in figure 2 (curve 2).
    From a comparison of the kinetic curves 1 and 2 (Fig. 2), we can draw the following conclusions.
    The standard cell-free translation system reaches a plateau on protein synthesis after 1.5 hours. The amount of synthesized protein in this case is 0.76 pmol of envelope protein per 1 pmol of ribosomes.
    In the installation of continuous action, the synthesis of the envelope protein proceeds linearly during the time interval studied (15 hours), the amount of synthesized protein in 15 hours is 40 pmol per 1 pmol of ribosomes.
    In general, for the proposed model of a continuous plant, the efficiency of protein synthesis over 15 hours increases by more than 50 times.
    Example 2. Synthesis of the protein of the shell of phage MS 2 on the matrix 2 MS 2 RNA in the prokaryotic translation system of E. col i in the standard system and in the installation of continuous action.
    Solution (A) contains 20 mM Tris-HC.1, pH 7.4, 10 mM MgCl2, 100 mM NH4G1, 1 mM APT, 0.2 mM GTP, 5 mM creatine phosphate, 10 μg / ml cr. phosphate kinase, 25 mM Ј s leucine with a specific activity of 348 mCi / / mmol and 25 μM of each of the remaining amino acids. 3 ml of the incubation mixture prepared on buffer (A) contain 1 nmol of ribosomes 70S, 1 nmol of MS2 RNA, 3.5 units. & g80 protein fraction S100.
     .
    In a parallel experiment, solution (A) is continuously fed to a continuous installation of 3 ml of the same incubation mixture at a rate of 0.5 ml / h, and the reaction products are withdrawn from the reaction mixture at the same rate through the PM-30 ultrafiltration membrane. The reaction substrates (ATP, GTP, aMHHOKHcnosty) are continuously fed to the chamber containing the cell-free translation system and the reaction products (LIG, GDP, P-, synthesized protein) are removed.
    The standard cell-free translation system reaches a plateau on protein synthesis after 2 h. The amount of synthesized protein in this case is i, 1 lmol of protein per 1 pmol of ribosomes.
    Compare the kinetics of the synthesis of the protein of the shell in such a system at 37 ° C for 15 hours with the kinetics of synthesis in the standard cell-free system.
    11 pmol of protein per 1 pmol of ribosomes were synthesized in a continuous plant for 15 hours.
    Thus, the proposed method for the synthesis of polypeptides in a cell-free translation system provides a multiple increase in the reaction rate and system functioning in the long-term mode. As a result, the yield of the target product is increased several tens of times (as compared with the prototype).
    The process efficiency achieved allows the use of a method for the preparative synthesis of active polypeptides and proteins. Particularly important economic significance can be the production of polypeptides 15–50 amino acid residues in this way, since their production by chemical means is extremely expensive, and for methods of genetic engineering it is inaccessible in many cases.
    权利要求:
    Claims (1)
    [1]
    Q claims
    The method of producing peptides and proteins in a cell-free translation system using messenger RNAs with post-production isolation and purification of the final product, characterized in that, in order to increase the yield of the target product, by prolonging the lifetime of the translation system, from the reaction mixture of the synthesized product, continuous recovery of the concentration of consumable low molecular weight substances of amino acids, ATP, GTP, 5 regeneration of ATP and GTP from the resulting AMP and PPR, followed by return ATP and GTP generated in the traditional system.
    five
    0
     ffs uftff # ufjrv r. OGRCH
    Omfaf Lear, G)
    f Ye Yrat 8 гал гал гал У в в
    ff / rrSep cvxmtbapytttcrt fwrnrvmi
    Wheat germ
    40
    thirty
    20
    ten
    FIG. 2
    类似技术:
    公开号 | 公开日 | 专利标题
    SU1618761A1|1991-01-07|Method of producing peptides and proteins in cell-less translation system
    Kitadai et al.2018|Origins of building blocks of life: A review
    Dose1988|The origin of life: More questions than answers
    ILLANGASEKARE et al.1999|A tiny RNA that catalyzes both aminoacyl-RNA and peptidyl-RNA synthesis
    Ponnamperuma et al.1968|Current status of chemical studies on the origin of life
    Lodder et al.1998|Misacylated transfer RNAs having a chemically removable protecting group
    Yamada et al.1989|A high concentration of SecA allows proton motive force-independent translocation of a model secretory protein into Escherichia coli membrane vesicles
    US7306934B2|2007-12-11|Porous solid ion exchange wafer for immobilizing biomolecules
    JP3194928B2|2001-08-06|Pre-expression method of gene in cell-free system of conjugation transcription / translation
    Coletti-Previero et al.1989|Alumina-phosphate complexes for immobilization of biomolecules
    Musier-Forsyth et al.1994|Acceptor helix interactions in a class II tRNA synthetase: photoaffinity crosslinking of an RNA miniduplex substrate
    Kung et al.1973|Studies on the Role of Ribosomal Proteins L7 and L12 in the in Vitro Synthesis of β-Galactosidase
    Liu et al.2017|5 |-Oxazolones as effective aminoacylation reagents for the 3′-terminus of RNA
    Plankensteiner et al.2005|Prebiotic chemistry: the amino acid and peptide world
    Fitz et al.2007|Chemical evolution toward the origin of life
    Yamagata et al.1997|Condensation of glycylglycine to oligoglycines with trimetaphosphate in aqueous solution. II: catalytic effect of magnesium ion
    Green et al.1982|Purification and properties of a mammalian tRNA pseudouridine synthase.
    Gao et al.2011|Intermolecular Phosphoryl Transfer of N‐Phosphoryl Amino Acids
    Stroud et al.1975|Structure-function relationships in the serine proteases
    von der Haar et al.1981|Target Directed Drug Synthesis: The Aminoacyl‐tRNA Synthetases as Possible Targets
    Gardner et al.1974|Enzymatic regeneration of ATP from AMP and ADP part i. thermodynamics, kinetics, and process development
    Yamagata et al.1982|Formation of cyanate and carbamyl phosphate by electric discharges of model primitive gas
    Moore et al.1987|Enzymatic synthesis of novel glutathione analogs
    Zhao et al.2018|Phosphorus chemistry: the role of phosphorus in prebiotic chemistry
    EP0485608B1|1995-11-22|Method for obtaining polypeptides in a cell-free translation system
    同族专利:
    公开号 | 公开日
    JPH07110236B2|1995-11-29|
    EP0312617B1|1993-03-03|
    DE3878821D1|1993-04-08|
    WO1988008453A1|1988-11-03|
    JPH01503119A|1989-10-26|
    EP0312617A4|1990-07-03|
    FI886002A|1988-12-28|
    EP0312617A1|1989-04-26|
    HUT54420A|1991-02-28|
    AT86306T|1993-03-15|
    SU1441787A1|1990-09-23|
    引用文献:
    公开号 | 申请日 | 公开日 | 申请人 | 专利标题
    JPH02343B2|1980-09-08|1990-01-08|Nippon Kemifua Kk|
    DE152483T1|1983-08-22|1986-02-27|Kyowa Hakko Kogyo Co., Ltd., Tokio/Tokyo|METHOD FOR PRODUCING PEPTIDES.|
    JPH0636746B2|1985-08-24|1994-05-18|味の素株式会社|Method for producing L-glutamic acid|CA2064685C|1989-07-31|1996-06-18|Sergei Jurievich Ovodov|Method of preparing polypeptides in a cell-free translation system|
    WO1991002074A1|1989-07-31|1991-02-21|Institut Belka Akademii Nauk Sssr|Method for obtaining polypeptides in a cell-free translation system|
    CA2064754C|1989-07-31|1996-06-18|Vladimir Ivanovich Baranov|Method of preparing polypeptides in a cell-free translation system|
    DE4124132A1|1990-08-07|1992-02-13|Bendzko Peter|METHOD FOR PRODUCING PEPTIDES AND POLYPEPTIDES IN A CELL-FREE TRANSLATION SYSTEM|
    WO1994006928A1|1992-09-24|1994-03-31|The Public Health Research Institute Of The City Of New York, Inc.|Coupled replication-translation methods and kits for protein synthesis|
    CA2133355A1|1993-10-04|1995-04-05|Itaru Nitta|Method for producing polypeptide|
    GB9722131D0|1997-10-20|1997-12-17|Medical Res Council|Method|
    RU2169154C2|1999-03-25|2001-06-20|Институт белка РАН|Method of synthesis of polypeptides in cell-free system|
    US6537776B1|1999-06-14|2003-03-25|Diversa Corporation|Synthetic ligation reassembly in directed evolution|
    DE10011209A1|2000-03-08|2001-09-13|Roche Diagnostics Gmbh|Reactor for reacting low- and high-molecular components, especially for coupled in vitro transcription-translation protein preparation reactions, including reactor chamber containing swellable matrix|
    JP4061043B2|2000-12-28|2008-03-12|株式会社ポストゲノム研究所|Method for producing peptide etc. by in vitro transcription / translation system|
    GB0115841D0|2001-06-28|2001-08-22|Medical Res Council|Ligand|
    US9321832B2|2002-06-28|2016-04-26|Domantis Limited|Ligand|
    US20060002935A1|2002-06-28|2006-01-05|Domantis Limited|Tumor Necrosis Factor Receptor 1 antagonists and methods of use therefor|
    DE10137792A1|2001-08-06|2003-02-27|Erdmann Volker|Method of gene expression|
    DK1440083T3|2001-10-25|2013-03-25|Medical Res Council|MOLECULES|
    AU2003222717A1|2002-03-01|2003-09-16|Erdmann, Volker, A.|Streptavidin-binding peptide|
    CN101724071A|2004-10-08|2010-06-09|杜门蒂斯有限公司|Single domain antibodies against TNFRl and methods of use therefor|
    JP4441170B2|2002-11-28|2010-03-31|独立行政法人理化学研究所|Escherichia coli cell extract having mutation in S12 ribosomal protein and cell-free protein production method using the same|
    JP4477923B2|2003-05-22|2010-06-09|独立行政法人理化学研究所|Method for producing extract for cell-free protein synthesis and cell extract produced by the method|
    WO2005075660A1|2004-02-03|2005-08-18|Toyo Boseki Kabushiki Kaisha|Improved composition for cell-free protein synthesis|
    US7459290B1|2004-03-30|2008-12-02|Iowa State University Research Foundation, Inc.|Methods of using functional 30S subunits|
    DE102004032460B3|2004-06-30|2005-08-18|Rina-Netzwerk Rna Technologien Gmbh|In vitro synthesis of expression products, particularly proteins, in a cell-free system, comprises using a repetitive batch method, with periodic removal of metabolites and supplementation|
    JP2008029204A|2004-11-12|2008-02-14|Cellfree Sciences Co Ltd|Method for synthesizing cell-free protein|
    JP4868731B2|2004-11-17|2012-02-01|独立行政法人理化学研究所|Cell-free protein synthesis system derived from cultured mammalian cells|
    JP4787488B2|2004-11-19|2011-10-05|独立行政法人理化学研究所|Cell-free protein synthesis method using linear template DNA and cell extract therefor|
    EP2481424A1|2005-03-19|2012-08-01|Medical Research Council|Improvements in or relating to treatment and prevention of hepatitis C viral infections|
    EP2433635A1|2006-11-10|2012-03-28|Massachusetts Institute Of Technology|PAK Modulators|
    US8226976B2|2007-11-05|2012-07-24|Riken|Method of using cell-free protein synthesis to produce a membrane protein|
    JP2010043063A|2008-05-09|2010-02-25|Agency For Science Technology & Research|Diagnosis and treatment of kawasaki disease|
    WO2021015095A1|2019-07-19|2021-01-28|大陽日酸株式会社|Protein production method and cell-free protein synthesis kit|
    RU199182U1|2019-12-10|2020-08-19|Федеральное государственное бюджетное учреждение науки Институт белка Российской академии наук |DEVICE FOR PROTEIN SYNTHESIS IN A CELLLESS SYSTEM|
    法律状态:
    优先权:
    申请号 | 申请日 | 专利标题
    SU874239148A|SU1441787A1|1987-04-29|1987-04-29|Method of producing peptides and proteins in cell-less translation system|
    [返回顶部]